Corporate Profile

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

 

lnk Overview

Read More

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

lnk Stock Information

View All Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

lnk Stock Information

View All Stock Information

News Releases

News and views about Intercure.

31-Oct-23

InterCure Wins Cannolam Arbitration Proceeding

NEW YORK and HERZLIYA, Israel , Oct. 31, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the leading medical cannabis company in Israel and outside of North America, reports today that, further to the Company’s press release
17-Oct-23

InterCure Provides an Update Regarding the Security Situation in Israel

NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the leading medical cannabis company in Israel and outside of North America, today addressed the status of the security situation in the
31-Aug-23

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Achieved record revenues of NIS 209 million ($ 7 5 million) 1 for the first half of 2023 Annualized revenue run rate of NIS 41 7 million ($ 149 million) Adjusted EBITDA 2 of NIS 30 million ($ 11 million) Generated NIS 35 million ($ 13 million) cash from operations in the second quarter Strong

lnk News

Events
Investor events will be posted soon.

lnk Events

View All Events
Featured Reports
Aug 16, 2022